Mainstay Medical receives Australian approval for neurostimulation implant

The Australian Therapeutic Goods Administration provided regulatory approval for Mainstay Medical’s ReActiv8 system.

Advertisement

Three insights:

1. ReActiv8 is restorative neurostimulation implant used to treat chronic lumbar pain.

2. The implant stimulates nerves that supply the lumbar multifidus muscle to generate contraction of the muscle, which can help patients recover from chronic lumbar pain.

3. Mainstay Medical aims to have ReActiv8 included in the Australian Prostheses List for private reimbursement in the third quarter of 2020.

More articles on devices:
9 spine, orthopedic surgeons performing surgeries on international medical missions
Minnesota hospital expands neurosurgery capabilities with 3 OR surgical suite, MRI machine
Meet the new president of Orthofix’s global spine business: Kevin Kenny

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.